当前位置:首页 - 行情中心 - 天域生物(603717) - 财务分析 - 现金流量表

天域生物

(603717)

  

流通市值:30.55亿  总市值:30.55亿
流通股本:2.90亿   总股本:2.90亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金440,759,800.45284,831,647.121,030,224,826.59768,234,309.54
  收到的税费返还72,168.9516,616.393,178,581.553,122,325.59
  收到其他与经营活动有关的现金86,194,348.8722,977,809.6478,550,210.8563,382,862.26
  经营活动现金流入小计527,026,318.27307,826,073.151,111,953,618.99834,739,497.39
  购买商品、接受劳务支付的现金332,540,324.98202,353,871.85734,712,564.7563,115,369.48
  支付给职工以及为职工支付的现金42,021,820.720,669,271.8287,298,182.9670,300,185.13
  支付的各项税费4,575,340.692,319,477.7317,333,538.989,343,404.11
  支付其他与经营活动有关的现金58,063,101.3535,527,930.71137,322,310.4186,755,128.09
  经营活动现金流出小计437,200,587.72260,870,552.11976,666,597.05729,514,086.81
  经营活动产生的现金流量净额89,825,730.5546,955,521.04135,287,021.94105,225,410.58
二、投资活动产生的现金流量:
  收回投资收到的现金--25,30125,301
  取得投资收益收到的现金--2,582,064.292,582,064.29
  处置固定资产、无形资产和其他长期资产收回的现金净额200-526,099.83325,986.83
  收到的其他与投资活动有关的现金535,404.98525,404.9819,550,573.7219,548,003.21
  投资活动现金流入小计535,604.98525,404.9822,684,038.8422,481,355.33
  购建固定资产、无形资产和其他长期资产支付的现金25,928,304.318,671,943.5154,019,050.2352,125,824.66
  投资支付的现金-9,800,000600,000600,000
  取得子公司及其他营业单位支付的现金20,740,000-15,862,540.0815,862,540.08
  支付其他与投资活动有关的现金159,649.09500,00017,091,369.1215,106,190.23
  投资活动现金流出小计46,827,953.418,971,943.5187,572,959.4383,694,554.97
  投资活动产生的现金流量净额-46,292,348.42-18,446,538.53-64,888,920.59-61,213,199.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金--196,000196,000
  其中:子公司吸收少数股东投资收到的现金--196,000196,000
  取得借款收到的现金44,166,931.4216,176,933.42234,275,726166,685,726
  收到其他与筹资活动有关的现金47,100,0008,800,000252,600,292.79186,185,292.79
  筹资活动现金流入小计91,266,931.4224,976,933.42487,072,018.79353,067,018.79
  偿还债务支付的现金37,879,867.7113,988,928.6228,477,037.19113,632,602.74
  分配股利、利润或偿付利息支付的现金18,491,837.389,119,273.743,307,389.1833,004,191.22
  支付其他与筹资活动有关的现金86,619,041.5941,342,175.71280,543,202.34230,368,350.95
  筹资活动现金流出小计142,990,746.6864,450,378.01552,327,628.71377,005,144.91
  筹资活动产生的现金流量净额-51,723,815.26-39,473,444.59-65,255,609.92-23,938,126.12
四、汇率变动对现金及现金等价物的影响83,888.4454,249.2288,368.3550,033.46
五、现金及现金等价物净增加额-8,106,544.69-10,910,212.865,230,859.7820,124,118.28
  加:期初现金及现金等价物余额100,267,192.32100,267,192.3295,036,332.5495,036,332.54
  期末现金及现金等价物余额92,160,647.6389,356,979.46100,267,192.32115,160,450.82
补充资料:
  净利润31,869,621.31--86,843,112.49-
  资产减值准备-7,161,672.76-15,837,153.91-
  固定资产和投资性房地产折旧19,265,407.3-37,028,608.27-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,265,407.3-37,028,608.27-
  无形资产摊销507,644.19-948,308.14-
  长期待摊费用摊销990,417.49-1,246,707.65-
  处置固定资产、无形资产和其他长期资产的损失-25,911,620.61-665,551.31-
  固定资产报废损失729,487.95-2,922,498.17-
  公允价值变动损失--428,240-
  财务费用32,651,064.3-38,544,388.32-
  投资损失1,060,660.84--214,519.02-
  递延所得税-130,174.51-3,171,264.85-
  其中:递延所得税资产减少-9,006.76-535,328.37-
    递延所得税负债增加-121,167.75-2,635,936.48-
  存货的减少185,576,376.81-95,257,003.96-
  经营性应收项目的减少-48,300,802.15--56,558,060.12-
  经营性应付项目的增加-113,750,762.9-30,376,004.13-
  其他---1,354,563.81-
  现金的期末余额92,160,647.63-100,267,192.32-
  减:现金的期初余额100,267,192.32-95,036,332.54-
  现金及现金等价物的净增加额-8,106,544.69-5,230,859.78-
公告日期2025-08-302025-04-302025-04-162024-10-31
审计意见(境内)标准无保留意见
TOP↑